ReviewNature reviews. Cardiology2019
Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.
Review in Nature reviews. Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 90 citations in OpenAlex.
- Trial
- Surgical repair of functional tricuspid regurgitation by drawing the anterior and posterior papillary muscles towards the septum, corrected regurgitation and restored physiologic valve kinematics.The Journal of thoracic and cardiovascular surgery · 2026Article
- Beating Tricuspid Surgery is a Viable Option with Similar Outcomes to Traditional Surgery: a Propensity Score Analysis.Brazilian journal of cardiovascular surgery · 2025Article
- Progression or persistence of tricuspid regurgitation after mitral valve replacement in patients with pre-operative moderate tricuspid regurgitation.Indian journal of thoracic and cardiovascular surgery · 2025Article
- Percutaneous interventions in tricuspid valve disease: a new era in cardiac treatment.Annals of medicine and surgery (2012) · 2025Review
- Tricuspid Regurgitation: A Comprehensive Review of Clinical, Imaging and Therapy.Reviews in cardiovascular medicine · 2025Review
- Review
- Caval Valve Implantation Procedure in 7 Cases of Torrential Tricuspid Regurgitation and Step-by-Step Description of the Procedure.Anatolian journal of cardiology · 2025Article
- Comparing outcomes of transcatheter tricuspid valve replacement and medical therapy for symptomatic severe tricuspid regurgitation: a retrospective study.European journal of medical research · 2024Observational
- Preconception Counseling for a Patient With a Mechanical Tricuspid Valve.JACC. Case reports · 2024Article
- Evolution of transcatheter interventions for secondary atrioventricular valve regurgitation: how to set up an edge-to-edge structural program.Cardiology journal · 2024Article
- Pharmacological Considerations during Percutaneous Treatment of Heart Failure.Current pharmaceutical design · 2024Review
- Acute Heart Failure During the Peripartum Period Due to Aggravated Tricuspid Regurgitation.JACC. Case reports · 2023Article
- A multifunctional soft robot for cardiac interventions.Science advances · 2023Article
- The relation of right ventricular outflow tract measurements with in-hospital clinical outcomes after tricuspid valve surgery.The international journal of cardiovascular imaging · 2023Article
- Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?Life (Basel, Switzerland) · 2023Review
- Transjugular Transcatheter Tricuspid Valve Implantation of LuX-Valve Bioprosthesis in a Preclinical Model.Journal of cardiovascular translational research · 2023Article
- Tricuspid regurgitation: a hidden risk factor for atrial fibrillation related stroke?Frontiers in cardiovascular medicine · 2023Article
- Texas TriValve 1.0 : a reverse‑engineered, open model of the human tricuspid valve.Engineering with computers · 2022Article
- Managing tricuspid valve pathology in multiple valvular heart disease.Annals of medicine and surgery (2012) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid valve disease, and particularly tricuspid regurgitation, is a highly prevalent condition with a complex pathophysiology and long-term adverse consequences. Although historically neglected, tricuspid valve disease has gained increasing recognition, with important advances in the assessment and management of this disorder over the past 2 decades. Surgical treatment remains the standard of care, but it continues to have one of the the highest death rates among all cardiac valve-related procedures, and a broad range of patients still do not receive effective therapy for tricuspid valve disease in contemporary clinical practice. Therefore, several alternative, less-invasive technologies for treating patients with severe, native tricuspid valve disease at high surgical risk have been developed in the past decade, with promising early results. This Review summarizes key findings and highlights the latest developments in the diagnosis and management framework that are transforming clinical practice in the complex field of tricuspid valve disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.